$VSQTF Invests in Top Three Companies at World Blockchain Forum

VANCOUVER, British Columbia, May 02, 2018 — Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) returns from the World Blockchain Forum: Investments & ICOs Conference in Dubai, United Arab Emirates, with newly-formed partnerships and investments in three promising blockchain companies that won awards for their presentations in Dubai.

The longest-running and highest-attended financial conference for the bitcoin, blockchain and cryptocurrency industries in the Middle East saw over 1,000 attendees converge in Dubai for the two-day event that took place April 16 and 17, 2018. It saw Victory Square partner with Keynote, the World Blockchain Forum to present the top 3 ICOs Award at the event. The three emerged from the 30 companies that were vetted and selected by the World Blockchain Forum to present their ICOs (with those 30 drawn from an initial pool of applicants).

Victory Square management viewed the presentations of the 30 ICO attendees and conducted Q&A sessions with the management teams of the shortlisted companies. Through this vetting process, Victory Square identified three companies as the top 3 ICOs – companies with which they will explore further relationships. Each of the identified companies will receive $33,000 towards the private sale of their respective tokens. In exchange, Victory Square will receive discounted tokens in the companies’ private pre-sale.

The top 3 companies selected by Victory Square management to share in the $100,000 investment prize pool were: SBC Platform, CryptoCurve, and Paytomat.

Peter Smyrniotis, a member of the Board of Directors of Victory Square, also presented at the conference, outlining Victory Square’s involvement in the blockchain industry and its track record of incubating some of the most promising and disruptive companies.

“This year’s World Blockchain Forum in Dubai featured yet again an impressive collection of the most forward-thinking minds in the blockchain industry,” said Smyrniotis. “We are very proud to be partnered with some of the brightest visionaries on the forefront of this technological revolution. Victory Square’s continued growth and success have been well met by our peers, and we have received strong validation and support for the global brand that we are building. The ability to share our vision and collaborate with other like minds provides the backbone of the structure that will support the technological world in the years to come.”

About the Top Three ICO Award Winners:

PAYTOMAT (www.paytomat.com)
Paytomat offers real life applications to various cryptocurrencies by enabling local stores and online merchants to accept payments in crypto. They serve as a liquidity network, a point of sale interface, a smart asset platform and provide a loyalty program with incentives for merchants and customers alike. Over 150 merchants already use the platform in the Ukraine and are looking to go international.

“We are very thankful to be selected as one of the winners of this year’s competition. We thank the organizers, Victory Square, and the judges for this competition as it is a brilliant place to be to showcase what we have been working very hard to achieve,” said Yurii Olentir, co-founder of Paytomat.

CryptoCurve (https://www.cryptocurve.io)
CryptoCurve offers what is called the Curve Wallet; “The Browser to Blockchain”. It aims to be the first and last wallet an investor will ever need and offers a wide array of next gen features that are industry firsts. Curve will be the first wallet to tie multiple blockchains to a decentralized network of buyers and sellers and provide the ability for 3rd party partners to build on top of their front end. This all-in-one solution further enables users to invest in ICOs, Stake ICOs, pool ICOs, while acting as a fiat gateway that tracks user portfolio values in real time.

“We extend our thanks to Victory Square and the partners who organized this event. We could not ask for a better public debut by being selected as best ICO pitch at the World Blockchain Forum of 2018 in Dubai,” said Joshua Halferty, CEO of CryptoCurve. “It was a pleasure to present in front of this incredible audience and cannot wait for what the future has in store for this team as we bring our Curve Wallet to the masses in the near future.”

SBC Platform (www.sbcplatform.com)
The SBC Platform aims to be the world’s first automated ICO solution for startups and SMEs. Over 20 industry professionals work on this platform to achieve a groundbreaking reduction in the cost of preparing quality projects for the ICO market by using cutting-edge technology. This product will help enable business people to carry out expert evaluation of their business concept, get legal advice and, having prepared all relevant documents for ICO launch based on the platform, to inform prospective backers on their project. Their strategic objective is to serve as a powerful driver for the development of startups, small and medium sized businesses.

“Being awarded a winner of the ICO pitch competition is a great honour for our team. We extend our thanks to Victory Square and the World Blockchain Forum for putting on this great event,” said Georgy Lapin, CEO and co-founder of SBC Platform. “It was a great pleasure to present alongside these fantastic teams and we are excited to take this experience with us as we move forward. Our focus to be a powerhouse that drives blockchain technology worldwide for SMEs remains unwavering, and we are thrilled that our judges at Victory Square support us.”

Meanwhile, further to the World Blockchain Forum Dubai prize pool, previous tokens that Victory Square purchased have completed their token sales. Bluzelle, Neuromation, GBX, Debitum both completed their sales, cumulatively raising over $100M USD. Victory Square also sponsored the ICO pitch competition at the d10e conference in Tokyo, which took place April 28 – May 1, 2018.

Video of Victory Square presenting at the World Blockchain Forum: Investments & ICOs Conference:
https://www.youtube.com/watch?v=pVy7T6KsM1w&t=2s

For further information about the Company, please contact:

Investor Relations Contact – Prit Singh
Email: prit@victorysquare.com
Telephone: 905-510-7636

Media Contact – Howard Blank, Director
Email: howard@victorysquare.com
Telephone: 604-928-6066

ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square Technologies is a blockchain-focused venture builder that funds and empowers entrepreneurs to implement innovative blockchain solutions. Victory Square portfolio companies are disrupting every sector of the global economy including Virtual Reality, Artificial Intelligence, Personalized Health, Gaming and Film. Victory Square has a proven process for identifying game-changing entrepreneurs and providing them with the partners, mentorship and support necessary to accelerate their growth and help them scale globally. For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

FORWARD-LOOKING INFORMATION
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of Victory Square. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square, including future plans. Although Victory Square believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Victory Square can give no assurance that they will prove to be correct. Forward- looking statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

$PVOTF Named to the CSE25 Index

• Pivot Pharmaceuticals attains prestigious CSE25 status
• Recent acquisitions have extended the company’s portfolio in the cannabis space
• Numerous pharmaceutical and nutraceutical products in development pipeline

Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) announced on March 19, 2018, that it has been named to the CSE25 Index (http://cnw.fm/g1qK7). CSE25 is a conglomerate of the 25 largest companies by market capitalization listed on the Canadian Securities Exchange. This achievement adds to Pivot Pharmaceuticals’ status as a constituent of the CSE Composite Index, which provides a distinctly different risk/return profile than the broad Canadian equity market.

“With an impressive pipeline of bio-cannabis products, a strong intellectual property portfolio of formulation and delivery technologies, and the expected addition of ACMPR licensed Agro-Biotech, we are proud to be recognized as leaders on the Canadian Securities Exchange through our inclusion in the CSE25 Index,” Dr. Patrick Frankham, CEO of Pivot Pharmaceuticals, stated in the news release. “Being among the top 25 performers on the exchange validates our business strategy to become a vertically integrated health and wellness company with a rapidly expanding international presence. With all of the exciting opportunities ahead of us, we believe we will remain a consistent part of the CSE25 Index for years to come as we continue to drive shareholder value.”

In February 2018, Pivot Pharmaceuticals entered into a letter of intent for the acquisition of Agro-Biotech Inc., a cannabis cultivator located in Quebec. Agro-Biotech received its producer’s license on January 12, 2018. On completion of the proposed acquisition, Pivot will be able to conduct research and development and store cannabis derivatives not currently covered under ACMPR regulations. The company will also be in a position to process natural health products and export cannabis oils and concentrates to international markets, once it receives an export permit.

The company’s recent acquisitions also include Thrudermic, LLC, a company based in North Carolina that has developed a transdermal, lipid-based nano-dispersion technology for cannabinoid delivery. Pivot also acquired ERS Holdings, LLC in February 2018, a California-based company that holds patents for the production of powderized cannabis oil that can be added to beverages and baked goods.

Pivot Pharmaceuticals is a Vancouver-based biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals through proprietary drug delivery technologies via medical cannabis product division Pivot Green Stream Health Solutions (“PGS”). In early February 2018, the company announced that it had filed three provisional patents for cannabinoid-based product delivery technologies with the U.S. Patent Office. These are for its innovative transdermal nanotechnology, inhalation and mucus topical delivery platforms. Its BiPhasix™ Transdermal Drug Delivery technology has been tested in clinical trials approved by both the FDA and EMA. This delivery platform provides significant advantages over oral delivery technologies.

Pivot has a number of products in its pipeline that are in various stages of development. These target therapies for pain, inflammation, dermatology, eye disease and cancer supportive care. PGS-N005 is a cannabidiol (CBD)-based topical cream to treat female sexual dysfunction, a disorder that is estimated to affect up to 63 percent of women in the United States (http://cnw.fm/32ENj). The market for female sexual dysfunction disorder therapies is estimated to be more than $4 billion.

For more information, visit the company’s website at www.PivotPharma.com

More from CannabisNewsWire

• The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) Completes Successful IPO
• The Green Organic Dutchman Ltd. (TSX: TGOD) Lists on the TSX Today
• Marijuana Company of America, Inc. (MCOA) Set to Profit from the Growth of the Legal Hemp Market

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$CIIX CEO Warren Wang Exclusive New Audio Interview SmallCapVoice.com

AUSTIN, Texas, May 02, 2018 — SmallCapVoice.com, Inc. and ChineseInvestors.com Inc. (OTCQB:CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors announced today that the Company’s CEO, Warren Wang is featured in a new audio interview at SmallCapVoice.com, Inc.

The interview outlining CIIX’s current news and efforts can be heard at https://smallcapvoice.com/blog/5-1-18-smallcapvoice-interview-with-chineseinvestors-com-inc-ciix/.

Warren Wang called in to SmallCapVoice.com, Inc. to go over the recent news and highlights for the Company here in spring of 2018. Recently, the Company announced the new opening of a cryptocurrency and trading courses offered through its newly established Bitcoin Trading Academy LLC beginning in June 2018. Online courses will begin June 9, 2018.  Additional course information will be provided on http://www.newcoins168.com. Mr. Wang also touched on the CBD markets here in the United States and in China, plans to spin out their hemp division, CBD Technology, and much more.

In the interview Mr. Wang stated, “Many investors want to learn more about Cryptocurrency trading, but they are not getting involved because it may appear overwhelming. Our education is for the mainstream investor. Right now, I am not aware of any other companies offering this level of education in cryptocurrency and trading courses. We believe there is a large market for our courses.”

About SmallCapVoice.com. Inc.

SmallCapVoice.com, Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and its services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/

About ChineseInvestors.com (CIIX)

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online sales and direct sales of hemp-based products and other health related products.

For more information visit: ChineseInvestors.com

Visit and register https://www.newcoins168.com

Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom

Subscribe and watch our video commentaries: https://www.youtube.com/channel/UCriTFjFHCvDW_LBhiIeuLlQ/featured

Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh

Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom

https://www.facebook.com/Chineseinvestors.com.english

Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:
ChineseInvestors.com, Inc.
227 W. Valley Blvd, #208 A
San Gabriel, CA 91776

Investor Relations:
Alan Klitenic
+1-214-636-2548

Corporate Communications:
NetworkNewsWire (NNW)
New York, New York
http://www.NetworkNewsWire.com
+212-418-1217 Office
Editor@NetworkNewsWire.com

For SmallCapVoice.com

Stuart T. Smith

512-267-2430

info@smallcapvoice.com

$PBIO CEO Hosts Webinar

• Company to Discuss Expected Impact on 2018 Revenue from
• Recent Product Enhancements, New Field Salesforce,
• BaroFold Technology Asset Acquisition, and Newly Issued Patents

SOUTH EASTON, MA / May 2, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, today announced that Mr. Richard T. Schumacher, President and CEO of PBI, will host a webinar update and live Q&A session for investors on Wednesday, May 2, 2018, at 3:00 pm EDT. The webinar will include discussions on enhancements made to products in the Company’s core Research Products & Services business segment, the Company’s new field salesforce, the acquisition of all assets of BaroFold Corporation, and the issuance of patents on the Company’s cutting-edge Ultra Shear Technology (“UST”) platform. The Company will also offer a brief outlook for the 2018 fiscal year.

RedChip’s Global Online Growth Conference brings together investors and executives of leading small-cap companies, representing a broad spectrum within the small cap sector. More than 10,000 investors attend RedChip’s Online Growth Conference series each year. No registration is required to participate in the conference. Start times are subject to change.

To view the webinar, please visit: https://www.redchip.com.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow immediate entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. http://www.pressurebiosciences.com

Forward Looking Statements

Statements contained in this press release regarding PBI’s intentions, hopes, beliefs, expectations, or predictions of the future are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company’s current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President & CEO, PBI (T) 508-230-1828
Victor Roberts, RedChip Companies (T) 407-644-4256 (111)
victor@redchip.com

$SABR Alaska Airlines successfully migrates Virgin America into Sabre

SOUTHLAKE, Texas, May 1, 2018 — Sabre Corporation (NASDAQ: SABR) and Alaska Airlines have successfully migrated Virgin America to Alaska’s passenger services system (PSS), hosted by Sabre. The recently completed migration will allow Alaska and Virgin America to move forward using Sabre systems as one unified airline while offering a seamless, end-to-end guest experience.

“Since initiating the merger with Virgin America, Alaska’s primary focus has been on the 44 million guests that collectively choose our airlines each year – and expanding our technology platform to best serve every one of them,” said Shane Tackett, Alaska Airlines’ senior vice president of revenue management and e-commerce.  “Along with the passion and commitment to a successful migration from our employees, Sabre’s partnership has been invaluable to realizing this mission-critical transition.”

Sabre and Alaska have been engaged for the last year building the foundation for Alaska’s growth and superior customer experience.  The successful migration is an example of the companies’ deeply collaborative relationship. Now that the integration is complete, Alaska will expand its use of Sabre’s customer management technology across the enterprise to fulfill its brand promise, enhance retailing capabilities and offer guests the best options in an ultra-competitive environment.

“Sabre is delighted to continue a rich partnership with Alaska Airlines – which is consistently ranked as one of the top airlines in North America – and assist them in executing their complex merger with Virgin America,” said Jeff Fullmer, vice president and regional general manager, Sabre Airline Solutions, North America.  “We experienced terrific collaboration between our teams throughout the migration process and look forward to supporting Alaska’s ongoing innovation and technology objectives.”

In December 2017, Alaska Airlines renewed its longstanding partnership with Sabre, including access to full content through the global distribution system (GDS) and an expansion of Alaska’s passenger services system. Alaska Airlines and its regional partners fly 44 million guests a year to more than 115 destinations, with an average of 1,200 daily flights across the United States, Mexico, Canada and Costa Rica.

About Sabre

Sabre Corporation is the leading technology provider to the global travel industry. Sabre’s software, data, mobile and distribution solutions are used by hundreds of airlines and thousands of hotel properties to manage critical operations, including passenger and guest reservations, revenue management, flight, network and crew management. Sabre also operates a leading global travel marketplace, which processes more than US$120 billion of global travel spend annually by connecting travel buyers and suppliers. Headquartered in Southlake, Texas, USA, Sabre serves customers in more than 160 countries around the world.

SABR-F

$SNNVF Reports Fiscal 2017 Financial, Operational Results

VANCOUVER, British Columbia, April 30, 2018 — via NetworkWire – Sunniva Inc. (“Sunniva” or “the Company”) (CSE:SNN) (OTCQX:SNNVF), a North American provider of cannabis products and services, today released its financial results and management’s discussion and analysis for the three months and year ended December 31, 2017. All figures are reported in Canadian dollars ($). Sunniva’s financial statements are prepared in accordance with International Financial Reporting Standards.

Message from the CEO

“2017 was a transformative year for Sunniva establishing the necessary infrastructure to become one of the largest vertically integrated cannabis companies operating in the world’s two largest cannabis markets – Canada and California. It has taken us many years to navigate strict federal and state legislative frameworks in California and the recent US presidential support of the legislative rights of individual states affirms our vision of becoming the leading provider of clean, medical grade cannabis within the Golden State,” said Tony Holler, CEO of Sunniva.

“Our vision is to become one of the lowest cost, highest quality cannabis producers in these markets by building large scale purpose-built current good manufacturing practices (“cGMP”) designed greenhouses and establishing sophisticated distribution channels, including our ownership of Natural Health Services (“NHS”) cannabis clinics in Canada which has surpassed 95,000 active patients as of today, to purchase the significant quantities of high quality Sunniva branded and Sunniva private label cannabis products. Our focus moving forward is to execute and de-risk our business model by forward selling a large portion of our production in both markets, supplementing the previously announced 90,000 KG take or pay contract with Canopy Growth in Canada, with an emphasis on creating long term shareholder value.”

“2017 was a year of building and 2018 will be the year of execution for our team to drive significant revenue in the near future. The major focus and milestones for the Company over the next year will be:

• Completing construction and commencing operations in our large-scale cGMP greenhouse facilities in both Canada and California.

• Finalizing debt financing for the estimated $120 million construction costs of the Sunniva Canada Campus.

• Securing additional long-term supply contracts in both markets.

• Leveraging the NHS doctor and software platform to capture a significant percentage of the Canadian medical cannabis market.

• Establishing a global Sunniva brand – a trusted source of high quality cannabis flower and extracted products and services.”

Financial Highlights – Year ended December 31, 2017

Consolidated Financial Highlights Expressed in 000’s of CDN$, except per share amounts

Operating Highlights –  Year ended December 31, 2017

Key operating highlights for the Company for the year included:

• In Cathedral City, California the Company acquired 20 acres of land and 18 licenses to produce and distribute cannabis in California.  The Company subsequently received its Conditional Use Permit from the City of Cathedral City which permitted construction to commence on the Company’s 489,000 square foot purpose-built cGMP designed greenhouse facility.  The facility is being financed by a related party of the Barker Pacific Group, Inc. as part of the sale and lease back of its greenhouse facility.

• The Company acquired NHS, one of the largest aggregators of medical cannabis patients in Canada.

• The Company acquired Full-Scale Distributors, LLC operating through the brand Vapor Connoisseur, a provider of custom private label vaporizers and cartridges to over 80 brands in North America.

• The Company acquired two leases and extraction licenses in Cathedral City for volatile and non-volatile extraction.

• The Company raised approximately $25.7 million in private placement financings of common shares, special warrants and convertible debentures.

Results of Operations – Year Ended December 31, 2017

During Fiscal 2017, the Company completed its first year of revenue generation with a total of $16.1 million in revenue for the year ended December 31, 2017. Revenue was generated from its two acquisitions during the period, NHS and FSD, which contributed $11.3 million and $4.8 million in revenue, respectively. Net loss for the year ended December 31, 2017 was $18.5 million as compared to $6.9 million during the year ended December 31, 2016.

The primary factors affecting the magnitude and variations of the Company’s losses are as follows:

In the year ended December 31, 2017 the Company incurred $14.3 million in selling, general and administrative expenses. The Company also incurred costs of goods sold of $9.4 million on a consolidated basis consisting primarily of contract physician compensation in NHS and product manufacturing costs in FSD.

During the year ended December 31, 2017, the Company incurred non-cash expenses of $6.3 million resulting from a fair value increase in its convertible promissory notes and warrants; an expense of $2.5 million resulting from the amortization of intangible assets acquired with NHS and FSD; and share-based compensation expense of $4.0 million. The expenses were applied to the Consolidated Statements of Comprehensive Loss for the year.

The Company incurred a net loss of $18.5 million for the year ended December 31, 2017. On a comparative basis, the net loss increased from the year ended December 31, 2016 by $11.6 million.

The key components contributing to the change in net loss from the year ended December 31, 2017 compared to the year ended December 31, 2016 was comprised of the following:

• Expense due to the revaluation of secured convertible promissory notes and warrants of $6.3 million that occurred in the year ended December 31, 2017.

• Costs of goods sold increased from $nil to $9.4 million resulting from the revenue generating activities of NHS and FSD.

• An increase in costs related to selling, general and administration expenses from $3.6 million to $14.3 million due to the acquisition of two operating companies NHS and FSD and the Company’s overall growth.

• Expenses for the period resulting from the amortization of acquired intangible assets in the amount of $2.5 million for the year ended December 31, 2017.

• Expenses were offset by an increase in revenue from $nil to $16.1 million the year ended December 31, 2017. In addition, deferred revenue increased from $nil as at December 31, 2016 to $0.7 million as at December 31, 2017, resulting from customer deposits on sales of merchandise.

Results of Operations – Three Months Ended December 31, 2017

During the fourth quarter of Fiscal 2017, the Company generated $5.9 million in revenue compared to $nil revenue in the fourth quarter of Fiscal 2016. Revenue was generated from its two acquisitions during Fiscal 2017, NHS and FSD, which contributed $3.9 million and $2.0 million in revenue respectively. Net income for the fourth quarter of Fiscal 2017 was $0.2 million as compared to a net loss of $1.4 million during the fourth quarter of Fiscal 2016.

The primary factors affecting the magnitude and variations of the Company’s losses are as follows:

In the fourth quarter of Fiscal 2017 the Company incurred $5.2 million in selling, general and administrative expenses. The Company also incurred costs of goods sold of $3.4 million on a consolidated basis consisting primarily of contract physician compensation in NHS and product manufacturing costs in FSD.

During the fourth quarter of Fiscal 2017, the Company realized a non-cash recovery of $2.4 million resulting from a fair value decrease in its convertible promissory notes and warrant liability; a recovery of $1.4 million resulting from the finalization of the NHS purchase price allocation and the resulting impact on amortization of the intangible software assets; and share-based compensation expense of $0.7 million. The expenses were applied to the Consolidated Statements of Loss and Comprehensive Loss for the period.

The Company earned net income of $0.2 million for the fourth quarter of Fiscal 2017 compared to a net loss of $1.4 million in the fourth quarter of Fiscal 2016. The key components contributing to the change in net loss from the fourth quarter of Fiscal 2017 compared to the fourth quarter of Fiscal 2016 was primarily related to:

• Recovery due to the revaluation of secured convertible promissory notes and warrants of $2.4 million that occurred in the fourth quarter of Fiscal 2017.

• Costs of goods sold increased from $nil to $3.4 million resulting from the revenue generating activities of NHS and FSD.

• An increase in costs related to selling, general and administration expenses from $0.9 million to $5.2 million due to the acquisition of two operating companies NHS and FSD, share-based compensation and the Company’s overall growth.  This was offset by an increase in revenue from $nil to $5.9 million in the period.

• Recovery for the period resulting from the amortization of acquired NHS software in the amount of $1.9 million for the fourth quarter of Fiscal 2017.

Recent Operating Developments Subsequent to December 31, 2017

For a comprehensive overview of Sunniva’s Recent Developments, please refer to the Company’s Management’s Discussion and Analysis of the Financial Condition and Results of Operations for the Three and Twelve Months Ended December 31, 2017.

• On January 10, 2018, the Company began trading its common shares on the Canadian Securities Exchange under the symbol “SNN”. On February 15, 2018 the Company began trading its common shares on the OTCQX Market, operated by OTC Markets Group, under the symbol “SNNVF”.

• On February 21, 2018 Sunniva and Canopy Growth Corporation (“Canopy Growth”) entered into a take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually which includes Canopy Growth purchasing and distributing Sunniva branded products.  Canopy Growth and Sunniva will share in the revenues as product is sold through Canopy Growth’s distribution network including its online marketplace, Tweed Main Street and via provincial distribution channels. The revenue share will be based on the strain, sales channel and other relevant factors.

• On February 15, 2018, the Company repaid the FSD note in cash of $2.8 million (US$2.2 million), plus accrued interest, and the remaining portion through the issuance of common shares at the conversion price of US$2.55 per share.

• On March 27, 2018 the Company completed a bought deal public offering for aggregate gross proceeds of $27.8 million. A total of 2,850,900 units (“Units”) and 50,000 Warrants (as defined below) were sold at a price of $9.75 per Unit and $0.02 per Warrant. Each Unit consists of one Common Share in the capital of the Company and one-half of one common share purchase warrant (each whole warrant, a “Warrant”) of the Company. Each whole Warrant shall entitle the holder thereof to acquire one common share at an exercise price per share of $12.50 for a period of 24 months.

• On April 12, 2018, Sunniva announced that its US subsidiaries received all the necessary State of California temporary licenses for phase one and two for its purpose built state-of-the-art greenhouse cultivation facilities in Cathedral City, California.

Copies of our audited annual financial statements and related management’s discussion and analysis of financial results are available on SEDAR at www.sedar.com.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale.  Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current good manufacturing practices greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices.  Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Sunniva operates through its wholly owned subsidiaries:

Sunniva Medical Inc. (“SMI”) – SMI is a late stage Access to Cannabis for Medical Purposes Regulations (“ACMPR”) applicant in final review and is building the Sunniva Canada Campus, 700,000 square feet of purpose-built cGMP compliant greenhouse facilities to be located in British Columbia. The total campus is expected to produce over 100,000 kg of premium medical cannabis a year and over 25,000 kg of trim used for extraction. The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. Sunniva anticipates breaking ground in the next two weeks. As the facility is not yet under construction, revenue and costs are not known, therefore, profitability cannot be assured.

CP Logistics, LLC (“CPL”) – Through CPL, Sunniva has commenced construction of the Sunniva California Campus, state-of-the-art, purpose-built greenhouse facilities in Cathedral City, California. The Sunniva California Campus is planned in two phases and has been cGMP designed. Phase 1 is designed to be 325,000-square feet producing in excess of 60,000 kg of premium cannabis a year. The total campus is expected to produce over 100,000 kg of premium cannabis a year after Phases 1 and 2 are complete. At this facility, it is estimated 30% of all product will be used for higher margin extracted products and all products will be produced free from the pesticides commonly used within today’s industry.  As the facility is not complete, revenue and costs are not known, therefore, profitability cannot be assured.

Natural Health Services Ltd. (“NHS”) – NHS owns and operates a network of 7 clinics in Canada specializing in medical cannabis under ACMPR.  NHS connects patients with safe and effective medical cannabis products through Licensed Producers (“LPs”). NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada. NHS has more than 150,000 active medical documents outstanding and 95,000 active patients.

Full-Scale Distributors, LLC (“FSD”) – FSD, through its brand, Vapor Connoisseur, is a provider of custom, private-label vaporizers and accessories. FSD currently serves the needs of over 80 brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative vaporization devices. Products are tailored to client needs, ensuring both safety and reliability and FSD will continue to provide these services in coordination with the large supply from both Sunniva Campuses.

For more information please visit: www.sunniva.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Sunniva’s plan to cultivate, produce and distribute a broad range of solutions focused on patients’ needs and Sunniva’s plans, timing and estimates of production for its facilities, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Contact Information:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Relations Contact:
George Jurcic
Manager, Investor Relations
587-430-0680
ir@sunniva.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NETE PayOnline Partners with Bank Sputnik

MIAMI, FL, May 01, 2018 — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (POS), e-commerce and mobile devices, today announces that its PayOnline subsidiary is partnering with Bank Sputnik to offer a comprehensive multi-channel payment facilitator solution for SMB merchants in the Russian Federation.  This unique solution offers a set of tools not available from any other transaction processing company in the region and expands PayOnline’s offerings beyond electronic commerce.

Bank Sputnik has entered into an exclusive partnership with PayOnline to offer a fully compliant legal framework and bank sponsorship to enable PayOnline to process transactions as a payment facilitator.  By provisioning a single, master merchant ID, PayOnline ensures merchants and their clients benefit from an automated, real-time and seamless onboarding experience. The API-driven platform simplifies merchant account enrollment.  A sub-merchant can be enrolled, approved, boarded and processing payments in a few minutes.

PayOnline merchants have instant access to a suite of value-added merchant solutions which include credit card auto account updater, multi-currency pricing, tokenization, advanced fraud detection tools and smart transaction routing. According to Statista Digital Markets report, the total transaction value in digital payments segment in Russia will amount to US$39.5 billion in 2018, up from US$27.9 billion in 2016. Total transaction value is expected to show an annual growth rate (CAGR 2018-2022) of 11.9% resulting in the total amount of US$61.8 billion in 2022.

“This innovative, turnkey solution offers frictionless onboarding for merchants with integrated, value-added services,” commented Andrey Krotov, CTO of Net Element. “With customizable payment flows, full-stack API and value-added solutions, PayOnline exceeds the unique needs of software platforms and merchants looking to enable payments in a multi-channel environment.”

About Bank Sputnik
Commercial “Sputnik” Bank was founded in 1990. Today, ” Sputnik” – is a universal bank providing a full range of banking services to both legal entities and individuals. The service package includes payment, credit, deposit, documentary and other operations carried out in Russian and foreign currencies. Further information is available at www.banksputnik.com.

About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S. it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, our cloud based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™.  In 2017, Net Element  was recognized by South Florida Business Journal as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include to whether the partnership with Bank Sputnik will be successful or yield any benefits to teh Company.  Additional  examples of such risks and uncertainties include, but are not limited to: (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Net Element, Inc.
1-786-923-0502
media@netelement.com

$DJACF Files Fiscal Year 2017 Results

Hiku closes the year poised for the adult use market in Canada

TORONTO, May 1, 2018 – Hiku Brands Company Ltd. (CSE: HIKU) (“Hiku” or the “Company”) is pleased to announce the filing of its financial statements and management discussion and analysis for the fiscal year ending December 31, 2017. These filings are available for review on SEDAR.

“2017 was a transformational year as we worked to establish a solid foundation for Hiku leading into Canada’s upcoming legalization of adult use cannabis,” said Alan Gertner, CEO of Hiku Brands. “In 2018, Hiku continues its mission to add to its portfolio of iconic brands, grow its retail footprint and enter into partnerships to advance the vision of becoming the preeminent vertically integrated cannabis brand house. With our recently announced merger with WeedMD, Hiku will immediately add 1,500 kg of indoor annual cannabis production capacity, fully funded production expansion capacity of more than 50,000 kg/yr and a well known, highly regarded medicinal brand. From our products to our in-store experiences, the combined company is poised to be a formidable force in the cannabis industry.” 

Fiscal Year 2017 Highlights

June

• Received License to Cultivate – Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd. (“DOJA”), received its license to cultivate under the ACMPR (Access to Cannabis for Medical Purposes Regulations) from Health Canada;

August

• Go-public – Completed a go-public transaction on the Canadian Securities Exchange

October

• Completed First Harvest – Harvested and cured DOJA’s first batches of premium handcrafted cannabis flower in October at its Dominion facility in West Kelowna, British Columbia (with annual production capacity of 660 kg of dried flower);
• First DOJA Cafe Opened – Opened the first DOJA Cafe, a retail store in downtown Kelowna, focused on building brand awareness, cannabis education, and medical patient pre-registration. The location is non-cannabis dispensing and sells artisanal coffee, clothing and accessories;
• Secured Expansion Property – Purchased a building and land out of receivership in Kelowna, British Columbia, home to DOJA’s second site facility (the “FUTURE LAB”), which is anticipated to expand annual corporate production capacity by an additional 4,500 kg;

November

• FUTURE LAB Construction – Commenced construction on the FUTURE LAB, the facility will incorporate solar power, LED lighting, two-tier vertical farming and a state-of-the-art extraction lab;

December

• Imported Cannabis Seeds – Received an import permit from Health Canada for cannabis seeds to build DOJA’s genetics library to differentiate the brand, not only through its products and approach to the market, but also by curating a diverse and proprietary cultivar offering;
• Raised $20 Million – Strengthened the Company’s balance sheet by a total of $20 million through equity and convertible debt financings;
• DOJA & Tokyo Smoke Merger – Announced a transformational merger of DOJA and TS Brandco Holdings Ltd. (“Tokyo Smoke”), bringing together industry leading management teams, British Columbia curated handcrafted cannabis production, a portfolio of visionary brands and a growing nationwide retail footprint; and
• Aphria Strategic Investment – Announced a strategic financing of $12.5 million led by Aphria Inc. (Hiku subsequently closed the financing on January 9, 2018.)

2018 Highlights to Date

January

• Launched Hiku – The merger of DOJA and Tokyo Smoke closed and the combined company was renamed Hiku Brands Company Ltd. – becoming Canada’s first vertically integrated cannabis brand house and uniting the cannabis brands DOJA, Tokyo Smoke, and Van der Pop;

February

• Added Quebec Brand – Hiku signed a binding LOI with Maïtri Group Inc, a Quebec based cannabis brand, to acquire 100% of the issued and outstanding shares (Hiku subsequently entered into the definitive agreement on April 30);
• Awarded Manitoba Retail License – Tokyo Smoke, with participation of BOBHQ, was conditionally awarded one of four master retail licenses in Manitoba’s Request for Proposal process for the right to operate retail cannabis stores. The license gives Tokyo Smoke the ability to operate legal retail cannabis stores and an online cannabis e-commerce platform in Manitoba;
• Entered into First International Partnership in Jamaica – Hiku entered into a LOI with Kaya Inc., the first licensed medical cannabis producer and dispensary operator in Jamaica, to launch a strategic alliance to pursue medical and adult-use cannabis branding, genetics, and retail opportunities in Jamaica and Canada;

March

• Announced Cannabis Oil Partnership – Signed a strategic partnership agreement with Vitalis Extraction Technology Inc., a Kelowna based company at the forefront of CO2 extraction innovation;
• Bolstered Leadership Team – Made several key additions to the leadership team with significant expertise in retail, branding, government relations and communications;
• Redefining the Cannabis Retail Experience – Entered into an exclusive collaboration agreement with Jackman Reinvention Inc. (a strategic and creative brand consultancy with deep experience in retail execution) to create a blueprint for Hiku’s dispensary build-outs in select provinces;
• Bringing Exceptional Products to Market – Entered into a letter of intent to establish a co-marketing, retail and select distribution relationship with dosist (previously known as hmbldt), a leading wellness brand providing consistent, controlled and effective cannabis-based solutions

April

• Received Sales License – DOJA received an amendment to its sales license from Health Canada to include the sales of dried cannabis, cannabis plants and seeds; and
• Hiku & WeedMD Merger – Hiku entered into a definitive agreement to merge with WeedMD, combining a premium cannabis brand house and retail focused operator in Hiku, with the significant production capabilities and differentiated medical brand in WeedMD. The combined company will have a diversified cannabis cultivation platform with four facilities from coast-to-coast with planned expansion capacity to have the ability to produce over 56,000 kg by mid-2019.

Definitive Agreement with Maïtri

Further to the press release dated February 1, 2018, Hiku is pleased to announce it has entered into a definitive share purchase agreement (the “Share Purchase Agreement”) to acquire 100% of the issued and outstanding shares ofMaïtri Group Inc. (“Maïtri”), a Quebec-based cannabis accessory and design brand (the “Acquisition”).

Pursuant to the Share Purchase Agreement, shareholders of Maïtri will receive upfront consideration of an aggregate of $550,000 in a combination of $50,000 cash and 318,471 Hiku shares (the “Consideration Shares”), and may earn up to an additional 764,329 Hiku shares in earn out and contingent payments if certain performance milestones are met. A portion of the Consideration Shares will be held in escrow and released to the shareholders of Maïtri over twenty-four months following the closing of the Acquisition. The parties intend to proceed to close the Acquisition as soon as possible and in accordance with the Canadian Securities Exchange policies.

About Hiku Brands

Hiku is focused on building a portfolio of engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production. With a national retail footprint led by Tokyo Smoke, craft cannabis production through DOJA’s ACMPR licensed grow, and Van der Pop’s female-focused educational platforms, Hiku houses an industry-leading portfolio that aims to set the bar for cannabis brands in Canada.

Hiku’s wholly-owned subsidiary, DOJA Cannabis Ltd., is a federally licensed to cultivate and sell cannabis pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. Hiku’s wholly-owned subsidiary, Tokyo Smoke has been conditionally awarded one of four master retail licenses in Manitoba. Hiku also operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Forward-looking statements

This news release contains statements that constitute “forward-looking statements”. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Hiku’s actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects,” “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential” and similar expressions, or that events or conditions “will”, “would”, “may”, “could” or “should” occur.

Forward-looking statements in this document include, among others, the Company’s expectations concerning the completion of the merger with WeedMD and the planned production capacity of the combined company. By their nature, forward-looking statements are based on the opinions and estimates of management at the date the information is made, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Hiku is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The Canadian Securities Exchange has not approved nor disapproved the contents of this news release.

SOURCE Hiku Brands Company Ltd.

$ETST Aims to Complete White Paper Studies in Early 2019

• ETST will investigate combination drugs that combine a mineral element with full spectrum cannabinoid industrial hemp oil; it anticipates completion of white paper studies in early 2019, with clinical trials to follow
• Goal is to produce both an OTC nutraceutical product and a cannabinoid companion generic drug to fight the epidemic of opioid dependency
• Foundations Wellness Center reports that two million Americans are now addicted to opioids

Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies of drugs that are intended to treat opioid dependency. It intends to test the effectiveness of combination drugs that contain a mineral element and full spectrum cannabinoid industrial hemp oil (http://cnw.fm/2SaKh).

The clinical trials are expected to commence in 2019 or later. The goal is to produce an over-the-counter (OTC) treatment drug and a cannabinoid companion generic drug to battle opioid dependency. The Foundations Wellness Center reported that two million Americans were addicted to opioids in 2015, the most recent full year for which those statistics are currently available (http://cnw.fm/7Fu55).

The trials are likely to investigate the synergies between mineral elements and cannabinoid industrial hemp oil for use as a treatment for opioid dependency. ETST could then be positioned to bring new products to the marketplace. Per company reports, one drug could be designed to reduce the cravings of opioid addicts and the other, a generic, could make the treatment more effective and reduce the danger of side effects.

Addiction can lead to death from opioids. The Washington Post quotes two specialists as saying that the final death count relating to opioid addiction in 2017 could reach 50,000, higher than the number of AIDS deaths at the peak of that epidemic (http://cnw.fm/52uGE).

ETST is a biotech company focused on the cannabinoid, pharmaceutical and nutraceutical markets, as well as conducting R&D for medical devices. It is a company that holds several operational subsidiaries, including Earth Science Pharmaceutical, Inc.; Cannabis Therapeutics, Inc.; and KannaBidioiD, Inc. In addition, the company holds a Montreal-based subsidiary, Canna Inno Laboratories, Inc., providing access to Canadian grants.

For more information, visit the company’s website at www.EarthScienceTech.com

More from CannabisNewsWire

• Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Developing Portfolio of Cannabis Companies
• Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Set to Gain from Hemp Legalization Drive in U.S.
• ChineseInvestors.com, Inc. (CIIX) Eyes Chinese Expansion with Establishment of Shanghai-Based Subsidiary

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net